NASDAQ:DRTS Alpha Tau Medical (DRTS) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free DRTS Stock Alerts $2.45 -0.04 (-1.61%) (As of 02:54 PM ET) Add Compare Share Share Today's Range$2.45▼$2.5650-Day Range$2.44▼$3.1452-Week Range$2.41▼$4.80Volume48,761 shsAverage Volume33,146 shsMarket Capitalization$170.69 millionP/E RatioN/ADividend YieldN/APrice Target$12.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Alpha Tau Medical alerts: Email Address Alpha Tau Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside387.8% Upside$12.00 Price TargetShort InterestHealthy0.08% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.51) to ($0.56) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.76 out of 5 starsMedical Sector633rd out of 907 stocksSurgical & Medical Instruments Industry73rd out of 96 stocks 3.5 Analyst's Opinion Consensus RatingAlpha Tau Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlpha Tau Medical has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.08% of the float of Alpha Tau Medical has been sold short.Short Interest Ratio / Days to CoverAlpha Tau Medical has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Alpha Tau Medical has recently decreased by 22.83%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAlpha Tau Medical does not currently pay a dividend.Dividend GrowthAlpha Tau Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DRTS. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Alpha Tau Medical this week, compared to 0 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alpha Tau Medical insiders have not sold or bought any company stock.Percentage Held by Insiders39.50% of the stock of Alpha Tau Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 2.65% of the stock of Alpha Tau Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Alpha Tau Medical are expected to decrease in the coming year, from ($0.51) to ($0.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Tau Medical is -5.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Tau Medical is -5.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Tau Medical has a P/B Ratio of 2.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Alpha Tau Medical Stock (NASDAQ:DRTS)Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.Read More DRTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DRTS Stock News HeadlinesMarch 25, 2024 | globenewswire.comAlpha Tau to Present at the Jefferies Radiopharma Innovation SummitMarch 12, 2024 | markets.businessinsider.comBuy Rating Affirmed: Anticipating Alpha Tau Medical’s Clinical Milestones and Growth Potential in 2024April 25, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. March 7, 2024 | globenewswire.comAlpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateFebruary 26, 2024 | globenewswire.comAlpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceJanuary 8, 2024 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS), Quotes and News SummaryDecember 20, 2023 | finance.yahoo.comAlpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNovember 28, 2023 | finance.yahoo.comAlpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerApril 25, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. November 20, 2023 | finance.yahoo.comAlpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 17, 2023 | markets.businessinsider.comAnalyst Ratings for Alpha Tau MedicalNovember 16, 2023 | msn.comAlpha Tau Medical GAAP EPS of $0.31October 30, 2023 | finance.yahoo.comAlpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilitySeptember 16, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Alpha Tau Medical's (NASDAQ:DRTS) Cash Burn SituationSeptember 14, 2023 | stockhouse.comAlpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical CenterAugust 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in September Investor ConferencesAugust 17, 2023 | finance.yahoo.comAlpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTAugust 2, 2023 | finance.yahoo.comAlpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023May 25, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)May 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in June Investor ConferencesMay 23, 2023 | msn.comRecap: Alpha Tau Medical Q1 EarningsMay 22, 2023 | finance.yahoo.comShould You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?May 18, 2023 | markets.businessinsider.comAlpha Tau Medical Ltd (DRTS) Receives a Buy from H.C. WainwrightMay 17, 2023 | finance.yahoo.comAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityMay 11, 2023 | finance.yahoo.comAlpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenMay 3, 2023 | finance.yahoo.comAlpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayApril 24, 2023 | msn.comAlpha Tau Medical a new buy at HC Wainwright on proprietary radiation therapySee More Headlines Receive DRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Today4/25/2024Next Earnings (Estimated)5/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:DRTS CUSIPN/A CIK1871321 Webhealthcarecapitalcorp.com Phone972-3577-4115FaxN/AEmployees121Year FoundedN/APrice Target and Rating Average Stock Price Target$12.00 High Stock Price Target$23.00 Low Stock Price Target$8.00 Potential Upside/Downside+381.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,160,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-31.86% Return on Assets-26.42% Debt Debt-to-Equity Ratio0.07 Current Ratio12.07 Quick Ratio12.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.21 per share Price / Book2.06Miscellaneous Outstanding Shares69,670,000Free Float42,151,000Market Cap$173.48 million OptionableOptionable Beta0.70 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Uzi Sofer (Age 54)CEO & Chairman Comp: $630kMr. Raphi Levy (Age 39)Chief Financial Officer Comp: $424kMr. Amnon Gat (Age 49)Chief Operations Officer Comp: $340kMr. Peter M. Melnyk (Age 62)Chief Commercial Officer Comp: $376kDr. Robert B. Den M.D. (Age 45)Chief Medical Officer & Member of Scientific Advisory Board Comp: $401kMr. Ronen Segal (Age 51)Chief Technology Officer Comp: $380kProf. Yona Keisari (Age 77)Chief Scientific Officer & Member of Scientific Advisory board Ms. Rebecca BeckerVice President of legalProf. Itzhak Kelson (Age 84)Chief Physics Officer & Member of Scientific Advisory Board Ms. Yael Zeiger (Age 41)Corporate Controller More ExecutivesKey CompetitorsQuipt Home MedicalNASDAQ:QIPTOrchestra BioMedNASDAQ:OBIOProfound MedicalNASDAQ:PROFClearPoint NeuroNASDAQ:CLPTDelcath SystemsNASDAQ:DCTHView All CompetitorsInstitutional OwnershipSatovsky Asset Management LLCSold 9,836 shares on 4/23/2024Ownership: 0.070%Levin Capital Strategies L.P.Bought 245,123 shares on 2/6/2024Ownership: 0.476%Private Advisor Group LLCBought 58,430 shares on 2/6/2024Ownership: 0.084%Telemus Capital LLCBought 29,716 shares on 2/1/2024Ownership: 0.043%View All Institutional Transactions DRTS Stock Analysis - Frequently Asked Questions Should I buy or sell Alpha Tau Medical stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alpha Tau Medical in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DRTS shares. View DRTS analyst ratings or view top-rated stocks. What is Alpha Tau Medical's stock price target for 2024? 4 Wall Street analysts have issued 12 month price objectives for Alpha Tau Medical's shares. Their DRTS share price targets range from $8.00 to $23.00. On average, they predict the company's stock price to reach $12.00 in the next twelve months. This suggests a possible upside of 387.8% from the stock's current price. View analysts price targets for DRTS or view top-rated stocks among Wall Street analysts. How have DRTS shares performed in 2024? Alpha Tau Medical's stock was trading at $3.01 at the beginning of the year. Since then, DRTS shares have decreased by 18.3% and is now trading at $2.46. View the best growth stocks for 2024 here. Are investors shorting Alpha Tau Medical? Alpha Tau Medical saw a decline in short interest in April. As of April 15th, there was short interest totaling 43,600 shares, a decline of 22.8% from the March 31st total of 56,500 shares. Based on an average daily volume of 32,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.1% of the shares of the company are sold short. View Alpha Tau Medical's Short Interest. When is Alpha Tau Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024. View our DRTS earnings forecast. How were Alpha Tau Medical's earnings last quarter? Alpha Tau Medical Ltd. (NASDAQ:DRTS) released its quarterly earnings results on Thursday, March, 7th. The company reported ($0.11) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.02. Who are Alpha Tau Medical's major shareholders? Alpha Tau Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Satovsky Asset Management LLC (0.07%). How do I buy shares of Alpha Tau Medical? Shares of DRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DRTS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
